FCRL3 and myeloid sarcoma: While the G allele of rs3761959 in FCRL3 was initially identified as a risk factor for MS in the primary GWAS phase, subsequent replication across diverse ethnic groups yielded inconclusive results, underscoring the influence of genetic diversity (12).